Global Health

China has had tremendous success containing the spread of COVID-19 while simultaneously being resistant to cooperating and collaborating with international partners to end the pandemic.

Thousands of Indians recovering from COVID-19 have come down with a rare fungal infection that's killing 50% of its victims. Doctors have had to remove patients' eyes and jawbones to save them.

The U.S. just backed calls by South Africa and India to waive intellectual property protection for COVID-19 vaccines, but that may not be enough to ramp up vaccine production.

The CDC has decided to focus investigations of cases in which the COVID-19 vaccines fail on people who get hospitalized or die, but critics say that's short-sighted.

The U.S. intelligence community is investigating the potential origins of the coronavirus, including the possibility that it emerged as a result of a lab accident in Wuhan, China.

As coronavirus restrictions are eased, how will travelers prove they've been vaccinated? Paper vaccination cards can be easily forged, damaged or lost and there's no universal digital passport yet.

They're treating as many as 200 patients a day. Many have seen more suffering than they expected in an entire career. A psychiatrist warns this will be "a generation of doctors who are traumatized."

Early in the pandemic, Taiwan was praised for handling COVID-19 exceptionally well. Now, Taiwan is struggling through its worst bout of coronavirus yet.

Hospitals are full. Testing is scant. Illiteracy is high. Most deaths are never registered. COVID-19's wrath in rural India is difficult to measure but public health experts are worried.

Ezekiel Emanuel, professor at the University of Pennsylvania, addresses the differences between PCR tests and rapid tests when it comes to getting tested before travel.

African nations had been counting on Serum Institute of India for nearly all their COVID vaccines. Now the company says it won't be sending any more for months. And African officials are scrambling.

The U.S. is one of five countries that allow companies to pay blood plasma donors, supplying 2/3 of the global need for it. Collection rates fell in the pandemic, threatening the health of recipients.